IDH mutation status is a fundamental division of gliomas and IDH mutant gliomas are fundamentally different from IDH wild-type gliomas, to the point where the WHO distinguishes them in the diagnostic criteria21. This evidence concerns the gene IDH1 and central nervous system cancer.